Literature DB >> 33384999

A Novel Autophagy-Related IncRNAs Signature for Prognostic Prediction and Clinical Value in Patients With Pancreatic Cancer.

Zhengdong Deng1, Xiangyu Li1, Yuanxin Shi1, Yun Lu1, Wei Yao2, Jianming Wang1,3.   

Abstract

Autophagy is an important bioprocess throughout the occurrence and development of cancer. However, the role of autophagy-related lncRNAs in pancreatic cancer (PC) remains obscure. In the study, we identified the autophagy-related lncRNAs (ARlncRNAs) and divided the PC patients from The Cancer Genome Atlas into training and validation set. Firstly, we constructed a signature in the training set by the least absolute shrinkage and selection operator penalized cox regression analysis and the multivariate cox regression analysis. Then, we validated the independent prognostic role of the risk signature in both training and validation set with survival analysis, receiver operating characteristic analysis, and Cox regression. The nomogram was established to demonstrate the predictive power of the signature. Moreover, high risk scores were significantly correlated to worse outcomes and severe clinical characteristics. The Pearson's analysis between risk scores with immune cells infiltration, tumor mutation burden, and the expression level of chemotherapy target molecules indicated that the signature could predict efficacy of immunotherapy and targeted therapy. Next, we constructed an lncRNA-miRNA-mRNA regulatory network and identified several potential small molecule drugs in the Connectivity Map (CMap). What's more, quantitative real-time PCR (qRT-PCR) analysis showed that serum LINC01559 could serve as a diagnostic biomarker. In vitro analysis showed inhibition of LINC01559 suppressed PC cell proliferation, migration, and invasion. Additionally, silencing LINC01559 suppressed gemcitabine-induced autophagy and promoted the sensitivity of PC cells to gemcitabine. In conclusion, we identified a novel ARlncRNAs signature with valuable clinical utility for reliable prognostic prediction and personalized treatment of PC patients. And inhibition of LINC01559 might be a novel strategy to overcome chemoresistance.
Copyright © 2020 Deng, Li, Shi, Lu, Yao and Wang.

Entities:  

Keywords:  LINC01559; autophagy-related lncRNA signature; chemoresistance; pancreatic cancer; prognostic prediction

Year:  2020        PMID: 33384999      PMCID: PMC7769875          DOI: 10.3389/fcell.2020.606817

Source DB:  PubMed          Journal:  Front Cell Dev Biol        ISSN: 2296-634X


  35 in total

Review 1.  How to build and interpret a nomogram for cancer prognosis.

Authors:  Alexia Iasonos; Deborah Schrag; Ganesh V Raj; Katherine S Panageas
Journal:  J Clin Oncol       Date:  2008-03-10       Impact factor: 44.544

2.  Gemcitabine resistance mediated by ribonucleotide reductase M2 in lung squamous cell carcinoma is reversed by GW8510 through autophagy induction.

Authors:  Ping Chen; Jian-Nong Wu; Yang Shu; He-Guo Jiang; Xiao-Hui Zhao; Hai Qian; Kang Chen; Ting Lan; Chen-Guo Chen; Jian Li
Journal:  Clin Sci (Lond)       Date:  2018-07-09       Impact factor: 6.124

3.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

4.  LINC01559 accelerates pancreatic cancer cell proliferation and migration through YAP-mediated pathway.

Authors:  Changjie Lou; Juan Zhao; Yuanlong Gu; Qingwei Li; Shuli Tang; Yangjiazi Wu; Jiebing Tang; Chunhui Zhang; Zhiwei Li; Yanqiao Zhang
Journal:  J Cell Physiol       Date:  2019-10-14       Impact factor: 6.384

Review 5.  Outcomes in operative management of pancreatic cancer.

Authors:  Lindsay A Bliss; Elan R Witkowski; Catherine J Yang; Jennifer F Tseng
Journal:  J Surg Oncol       Date:  2014-08-11       Impact factor: 3.454

6.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

7.  Ultrastructural analysis of pancreatic carcinogenesis. IV. Pseudoductular transformation of acini in the hamster pancreas during N-nitroso-bis(2-hydroxypropyl)amine carcinogenesis.

Authors:  B Flaks; M A Moore; A Flaks
Journal:  Carcinogenesis       Date:  1981       Impact factor: 4.944

Review 8.  Long noncoding RNAs and their link to cancer.

Authors:  Justine M Grixti; Duncan Ayers
Journal:  Noncoding RNA Res       Date:  2020-05-13

9.  Long noncoding RNA LINC01559 promotes pancreatic cancer progression by acting as a competing endogenous RNA of miR-1343-3p to upregulate RAF1 expression.

Authors:  Xiao Chen; Jie Wang; Fei Xie; Tinggang Mou; Pingyong Zhong; Hao Hua; Pan Liu; Qin Yang
Journal:  Aging (Albany NY)       Date:  2020-07-17       Impact factor: 5.682

Review 10.  Tumor microenvironment mediated by suppression of autophagic flux drives liver malignancy.

Authors:  Kuang-Den Chen; Chih-Che Lin; Ming-Chao Tsai; Kuang-Tzu Huang; King-Wah Chiu
Journal:  Biomed J       Date:  2018-06-29       Impact factor: 4.910

View more
  12 in total

1.  Risk Stratification and Validation of Eleven Autophagy-Related lncRNAs for Esophageal Squamous Cell Carcinoma.

Authors:  Xu Zhao; Yulun Wang; Fanbiao Meng; Zhuang Liu; Bo Xu
Journal:  Front Genet       Date:  2022-06-27       Impact factor: 4.772

2.  An Independent Prognostic Model Based on Ten Autophagy-Related Long Noncoding RNAs in Pancreatic Cancer Patients.

Authors:  Jiahui Tian; Chunyan Fu; Xuan Zeng; Xiaoxiao Fan; Yi Wu
Journal:  Genet Res (Camb)       Date:  2022-05-14       Impact factor: 1.375

3.  An EMT-Related Gene Signature for Predicting Response to Adjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma.

Authors:  Zengyu Feng; Kexian Li; Jianyao Lou; Yulian Wu; Chenghong Peng
Journal:  Front Cell Dev Biol       Date:  2021-04-30

4.  A novel tp53-associated nomogram to predict the overall survival in patients with pancreatic cancer.

Authors:  Xun Liu; Bobo Chen; Jiahui Chen; Shaolong Sun
Journal:  BMC Cancer       Date:  2021-03-31       Impact factor: 4.430

5.  Identification and Validation of Three Autophagy-Related Long Noncoding RNAs as Prognostic Signature in Cholangiocarcinoma.

Authors:  Ya Jun Liu; Alphonse Houssou Hounye; Zheng Wang; Xiaowei Liu; Jun Yi; Min Qi
Journal:  Front Oncol       Date:  2021-12-02       Impact factor: 6.244

6.  Construction of a Novel LncRNA Signature Related to Genomic Instability to Predict the Prognosis and Immune Activity of Patients With Hepatocellular Carcinoma.

Authors:  Jinfeng Zhu; Qian Huang; Sicheng Liu; Xingyu Peng; Ju Xue; Tangbin Feng; Wulang Huang; Zhimeng Chen; Kuiyuan Lai; Yufei Ji; Miaomiao Wang; Rongfa Yuan
Journal:  Front Immunol       Date:  2022-04-08       Impact factor: 8.786

Review 7.  Emerging role of lncRNAs in drug resistance mechanisms in head and neck squamous cell carcinoma.

Authors:  José A Peña-Flores; Mercedes Bermúdez; Rosalío Ramos-Payán; Carlos E Villegas-Mercado; Uriel Soto-Barreras; Daniela Muela-Campos; Alexis Álvarez-Ramírez; Brenda Pérez-Aguirre; Ana D Larrinua-Pacheco; César López-Camarillo; Jorge A López-Gutiérrez; Julio Garnica-Palazuelos; Marvin E Estrada-Macías; Juan L Cota-Quintero; Andrés A Barraza-Gómez
Journal:  Front Oncol       Date:  2022-08-01       Impact factor: 5.738

8.  Cuproptosis-related lncRNA predict prognosis and immune response of lung adenocarcinoma.

Authors:  Fangwei Wang; Hongsheng Lin; Qisheng Su; Chaoqian Li
Journal:  World J Surg Oncol       Date:  2022-09-01       Impact factor: 3.253

9.  Characteristic of Molecular Subtypes in Lung Squamous Cell Carcinoma Based on Autophagy-Related Genes and Tumor Microenvironment Infiltration.

Authors:  Jinjie Wang; Jiaqi Zhu; Yijie Tang; Anping Zhang; Tingting Zhou; Youlang Zhou; Jiahai Shi
Journal:  J Oncol       Date:  2022-09-13       Impact factor: 4.501

10.  Identification of autophagy-related long non-coding RNA prognostic signature for breast cancer.

Authors:  Qianxue Wu; Qing Li; Wenming Zhu; Xiang Zhang; Hongyuan Li
Journal:  J Cell Mol Med       Date:  2021-03-10       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.